Joseph M Massaro Selected Research

Stroke (Strokes)

12/2023	Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin.
1/2021	Transcranial direct current stimulation for post-stroke dysphagia: a systematic review and meta-analysis of randomized controlled trials.
10/2018	Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
8/2018	Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome.
1/2018	Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib.
1/2017	Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
1/2017	Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
1/2017	Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.
1/2017	Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
10/2016	Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph M Massaro Research Topics

Disease

42	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2003
32	Myocardial Infarction 12/2023 - 10/2004
24	Thrombosis (Thrombus) 10/2018 - 03/2007
23	Hypertension (High Blood Pressure) 01/2019 - 03/2003
20	Stroke (Strokes) 12/2023 - 08/2003
19	Hemorrhage 12/2019 - 10/2004
16	Heart Failure 12/2023 - 03/2013
11	Diabetes Mellitus 10/2018 - 07/2007
10	Atherosclerosis 01/2017 - 08/2004
9	Inflammation (Inflammations) 01/2021 - 07/2004
9	Coronary Disease (Coronary Heart Disease) 10/2017 - 11/2008
9	Obesity 12/2016 - 03/2003
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 07/2007
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 05/2010
7	Insulin Resistance 07/2013 - 01/2010
5	Chronic Renal Insufficiency 01/2019 - 03/2012
5	Acute Coronary Syndrome 10/2018 - 03/2012
5	Atrial Fibrillation 01/2018 - 10/2004
5	Ischemia 01/2018 - 03/2012
4	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2008
4	Ischemic Stroke 01/2020 - 08/2003
4	Dyslipidemias (Dyslipidemia) 01/2019 - 05/2011
4	Peripheral Arterial Disease 01/2017 - 01/2012
4	Non-alcoholic Fatty Liver Disease 01/2016 - 12/2008
3	Unstable Angina 12/2023 - 03/2012
3	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019 - 01/2014
3	Infarction (Infarctions) 05/2016 - 05/2014
3	Ventricular Remodeling 09/2012 - 05/2010
3	Death (Near-Death Experience) 05/2011 - 12/2010
2	Neoplasms (Cancer) 09/2017 - 01/2016
2	Cardiac Arrhythmias (Arrythmia) 01/2017 - 03/2012
2	Transient Ischemic Attack 01/2017 - 03/2004
2	Fatty Liver 01/2017 - 06/2010
2	Hypertriglyceridemia 01/2017 - 12/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2016 - 05/2011
2	Hypercholesterolemia 02/2016 - 06/2009
2	Fibrosis (Cirrhosis) 01/2016 - 03/2011
2	Isolated Systolic Hypertension 01/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

20	HDL CholesterolIBA 10/2018 - 03/2003
19	Triglycerides (Triacylglycerol)IBA 12/2016 - 07/2007
17	CalciumIBA 01/2021 - 11/2008
17	thienopyridineIBA 12/2019 - 12/2010
16	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 07/2007
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2005
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2004
11	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2017 - 12/2010
9	LipidsIBA 10/2019 - 02/2008
8	C-Reactive ProteinIBA 10/2018 - 03/2004
8	CholesterolIBA 01/2018 - 02/2009
5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
5	Cystatin CIBA 01/2019 - 03/2014
5	CreatinineIBA 01/2019 - 03/2003
5	Streptokinase FDA Link 01/2017 - 05/2015
5	HDL LipoproteinsIBA 01/2016 - 02/2008
5	Insulin (Novolin)FDA Link 05/2014 - 12/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 07/2015
4	Lipoproteins (Lipoprotein)IBA 01/2017 - 01/2016
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 05/2015
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2016 - 12/2004
4	Antihypertensive Agents (Antihypertensives)IBA 01/2016 - 06/2009
3	high fluorescent intermediate IIIBA 01/2022 - 01/2020
3	DiureticsIBA 01/2020 - 09/2012
3	LDL CholesterolIBA 10/2019 - 06/2009
3	Sirolimus (Rapamycin)FDA Link 10/2018 - 03/2007
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 03/2007
3	Warfarin (Coumadin)FDA LinkGeneric 10/2016 - 08/2003
3	Interleukin-6 (Interleukin 6)IBA 02/2016 - 12/2004
3	Transaminases (Aminotransferases)IBA 01/2016 - 12/2008
3	Alanine Transaminase (SGPT)IBA 01/2016 - 12/2008
3	MetalsIBA 10/2015 - 03/2007
3	PotassiumIBA 05/2014 - 03/2012
3	AdiponectinIBA 09/2012 - 05/2009
2	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2017
2	Plant NectarIBA 01/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 10/2018 - 02/2008
2	PolymersIBA 10/2018 - 10/2017
2	Everolimus FDA Link 10/2018 - 10/2017
2	Clopidogrel (Plavix)FDA Link 10/2016 - 12/2010
2	oxidized low density lipoproteinIBA 03/2016 - 12/2014
2	lipoprotein cholesterolIBA 03/2016 - 01/2016
2	AdipokinesIBA 02/2016 - 09/2012
2	IsoprostanesIBA 02/2016 - 02/2008
2	OsteoprotegerinIBA 02/2016 - 09/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 08/2010
2	ResistinIBA 09/2012 - 05/2009
2	Fibrinogen (Factor I)FDA Link 10/2011 - 05/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2005 - 07/2004
1	bexagliflozinIBA 12/2023

Therapy/Procedure

26	Therapeutics 01/2022 - 02/2009
26	Stents 10/2018 - 03/2007
7	Catheters 01/2019 - 09/2010
6	Percutaneous Coronary Intervention 10/2018 - 12/2010
6	Drug-Eluting Stents 01/2016 - 03/2007
3	Duration of Therapy 05/2016 - 03/2015
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2010 - 02/2008
2	Vagus Nerve Stimulation 01/2022 - 01/2020
2	Embolic Protection Devices 12/2012 - 04/2008
1	Art Therapy 01/2022